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We analysed the relation between adult breast cancer risk and adiposity in ages 8–25, and among 90509 women included in the
E3N cohort study, and investigated the potential modification effect of certain factors. Participants completed a questionnaire that
included a set of eight silhouettes corresponding to body shape at different ages. During the follow-up (mean¼11.4 years), 3491
breast cancer cases were identified. Negative trends in risk of breast cancer with increasing body silhouettes at age 8 and at menarche
were observed, irrespective of menopausal status, with relative risks of 0.73 (0.53–0.99) and 0.82 (0.66–1.02) for women who
reported a silhouette equal or greater than the fifth silhouette at age 8 and at menarche, respectively. We observed no clear effect
modification by age at menarche, delay between age at menarche, regular cycling, regularity of cycles in adult life or body mass index
at baseline.
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Adult adiposity is positively associated with postmenopausal
breast cancer risk and may be negatively associated with
premenopausal breast cancer risk (Choi et al, 1978; La Vecchia
et al, 1987; WCRF, 1997; COMA, 1998; van den Brandt et al, 2000;
Friedenreich, 2001; IARC, 2002; Okasha et al, 2003). It still remains
unclear, however, whether or not it is mostly excess weight during
puberty and adolescence that explains the inverse relation of breast
cancer risk with premenopausal overweight. In a number of
studies (Friedenreich, 2001; IARC, 2002; Alghren et al, 2004),
premenopausal breast cancer risk was inversely related to recalled
weight and body mass index (BMI) around the age of 18, whereas
the relation to weight gain since that age remains unclear, one
literature review indicating a direct relation (Friedenreich, 2001)
and another indicating an inverse relation (IARC, 2002). Among
studies on the relation between overweight and breast cancer,
seven case–control studies (Hislop and Coldman, 1986; Pryor
et al, 1989; Brinton and Swanson 1992; Franceschi et al, 1996;
Hu et al, 1997; Magnusson et al, 1998; Coates et al, 1999),
one historical cohort study (Le Marchand et al, 1988) and six
prospective cohorts (Hilakivi-Clarke et al, 2001; Swerdlow et al,
2002; Alghren et al, 2004; De Stavola et al, 2004; Weiderpass et al,
2004; Baer et al, 2005) have examined the relation between breast
cancer and adiposity in childhood. Only two studies (De Stavola
et al, 2004; Baer et al, 2005) investigated the interaction between
adiposity, between 2 and 4 years of age and age at menarche in
their relation to breast cancer. Studying the events occurring
during the period in life of the mammary gland growth may give
new insights into the aetiology of the disease.
We have examined the relation between breast cancer and body
shape at adolescence, using the data from the E3N study, a large
prospective cohort of French women, followed up from 1990 until
2002 (Clavel-Chapelon, 2002).
MATERIAL AND METHODS
The E3N cohort consists of 98995 women living in France, covered
by a national health insurance scheme primarily covering school
teachers. Participants were aged 40–65 years when they were first
recruited into the cohort, between June 1990 and November 1991,
by responding to the first in a series of mailed questionnaires
during their follow-up. The baseline questionnaire contained
questions on established risk factors of breast cancer including
aspects of reproductive life, menopause, history of benign breast
disease, breast cancer in first-degree relatives and anthropometric
measures. Women were also asked to report which of a series of
Sørensen’s silhouettes (Sørensen et al, 1983; www.e3n.net) best
described their body shape around the age of 8, at menarche and at
age 20–25 (Figure 1); more than 86% of women completed such
questions (Figure 1).
Follow-up questionnaires were sent out approximately every 2
years thereafter. All questionnaires asked whether breast cancer
had been diagnosed, requesting the addresses of their physicians
and permission to contact them. Deaths in the cohort were
detected from reports by family members and by searching the
insurance company (MGEN) file, which contains information on
vital status. Information on cause of death was obtained from the
National Service on Causes of Deaths (http://sc8.vesinet.in-
serm.fr:1080/accueil_fr.html). Information on nonrespondents
was obtained from the MGEN file on reimbursement of hospital
fees. The third follow-up questionnaire sent out contained a
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ydietary questionnaire. Participants of the E3N cohort who
responded to the dietary questionnaire (n¼74524) were included
in the European Prospective Investigation into Cancer and
Nutrition (EPIC) (Riboli and Kaaks, 1997).
Menopause, if applicable, was recorded in each follow-up
questionnaire. To promote accuracy of the constructed menopause
variables, all answers on date and type of menopause (natural or
the result of bilateral oophorectomy, chemotherapy, radiotherapy
or other treatment), date of last menstruation, date of start of
menopausal symptoms and date of hysterectomy, if appropriate,
were reviewed. Postmenopause was defined as the cessation of
periods for natural reasons or not.
Follow-up time was between the return of the baseline
questionnaire in 1990 and July 2002, when the seventh ques-
tionnaire was sent out. Person-years were accrued up to the date of
breast cancer diagnosis, death, last questionnaire returned or July
2002 (for replies to the questionnaire received after July 2002),
whichever occurred first. Women with a null follow-up were
excluded (n¼2601) from the analyses, as those who declared a
prevalent cancer other than a basal cell carcinoma and an incident
cancer other than a breast cancer (n¼5447). Also excluded were
women with an incident ductal carninoma in situ (n¼405).
Finally, 90509 women were included in the analyses; mean follow-
up was 11.4 years (s.d.¼2.4 years).
Owing to the high percentage of pathology reports finally
obtained (covering 94.9% of the breast cancers reported up to the
sixth questionnaires) and because of the high rate of histologic
confirmation (97.8% of these), we decided to consider in the
present analysis reported breast cancer cases not yet confirmed
(n¼527). Overall, the present analysis is based on 3491 breast
cancer cases, 930 diagnosed before the menopause and 2561
women after their menopause.
Statistical analyses were made using Cox’s proportional-hazard
models, with subjects’ age as the time scale. As menopausal status
changed during follow-up for 45573 women, it was included in
Cox’s models as a time-dependent variable in analyses that were
not stratified by menopausal status. The other adjustment
variables taken into account were: adult height divided into
quartiles (cut points: 158, 162 and 165cm), history of breast cancer
in first-degree relatives (yes/no), age at menarche (cut points: 12,
13 and 14), age at first full-term pregnancy (FFTP) (cut points: 23,
26 and 30), parity (0, 1–3 and4þ), history of benign breast disease
(yes/no), alcohol consumption (g of alcohol per week), number
of years at school (cut points: 0, 5, 9, 13 and 15), marital status
(if ever married or not), oral contraceptive use (yes/no) and
physical activity (quartiles of weekly energy expenditure for
recreational and household activities cited in the first question-
naire). Additional adjustments were made for BMI at recruitment,
the interval between menarche and the establishing of regular
menstrual cycles. The four largest silhouettes were grouped
together, according to the distribution.
RESULTS
Evidence for the following risk factors of breast cancer in the E3N
population were found (Table 1): early age at menarche, late age
at first birth, high height, low physical activity, high educational
level, familial history of breast cancer and personal history of
benign breast disease. Breast cancer cases on average also reported
a smaller silhouette than noncases, both at 8 years of age
(Po0.0001) and at menarche (Po0.0001). Concerning silhouette
at age 20–25, no difference was observed between cases and
noncases. Body silhouette at age 8 and at menarche were correlated
(Spearman’s correlation coefficient¼0.63, P-value o0.0001). Among
women who reported a silhouette at both ages (n¼80956), 45.6%
chose the same silhouette and 83.5% chose one at menarche that was
equal or adjacent to that at age 8. Body silhouette at age 20–25 was
found less correlated with that at age 8 (Spearman’s correlation
coefficient¼0.62, P-value o0.0001) than with that at menarche
(Spearman’s correlation coefficient¼0.44, P-value o0.0001).
Patterns of risks with silhouette at age 8 and at menarche were
similar among pre- and postmenopausal women (Table 2), with
significant negative trends in risk. In the whole group of pre- and
Table 1 Baseline (1990) characteristics
a of breast cancer cases and noncases, E3N study
Cases (n¼3491) Noncases (n¼87018) P-value
b
Age at inclusion (years) 50.0 (6.4) 49.2 (6.7) o0.0001
Age at menarche (years) 12.7 (1.4) 12.8 (1.4) o0.01
Age at first birth (years) 25.4 (4.3) 24.8 (4.1) o0.0001
Number of full-term pregnancies 1.9 (1.2) 2.0 (1.2) o0.0001
Years of education 13.9 (2.1) 13.4 (2.4) o0.05
Alcohol consumption (gday
 1) 10.6 (13.8) 10.7 (14.0) NS
Married 77.5% 77.7% NS
Oral contraceptive users 39.3% 41.4% o0.05
Benign breast disease cases 30.2% 22.7% o0.0001
First-degree relative breast cancer 21.3% 12.4% o0.0001
Height (cm) 162.0 (5.8) 161.7 (5.7) o0.005
Physical activity
c (METs) 45.4 (26.9) 47.1 (28.2) o0.005
Silhouettes
At 8 years old 1.7 (1.1) 1.9 (1.1) o0.0001
At menarche 2.4 (1.2) 2.5 (1.2) o0.0001
At age 20–25 2.5 (0.9) 2.6 (1.0) NS
NS¼nonsignificant.
aMean (s.d.) or percentages.
bCalculations were made by t-tests and w
2 tests.
cWeekly energy expenditure for recreational and household activities cited in
the first questionnaire.
12 345 678
At age 8 (n) 44  395
18 357 26 895 19 988 13 174 3739 772 151 26
17 179 11 150 6849 1635 434 75 14 8778
Missing
7407 At menarche (n)
Due to distribution, the four largest silhouettes were grouped together.
Figure 1 Body silhouettes used in baseline questionnaire (as first
proposed by So ¨rensen et al, 1983), with frequency distribution of women’s
responses.
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ypostmenopausal women, we observed a linear trend of decrease in
risk of breast cancer with increasing silhouette, both at age 8
(Po0.001) and at menarche (Po0.0005), with relative risks (RR)
equal to 0.86 (95% confidence interval (CI): 0.75–0.99) and 0.89
(0.80–0.99), for women who chose the fourth silhouette at age 8
and at menarche, respectively, and equal to 0.80 (0.63–1.02) and
0.90 (0.76–1.06) for women who chose a silhouette equal or greater
than the fifth silhouette at age 8 and at menarche, respectively, as
compared to women who chose the first silhouette (data not
shown). Considering silhouette at menarche, we observed a weak
increase in risk among women who chose the second silhouette
(RR equal to 1.11 (1.02–1.21)), as compared with the first. The
linear decreases in risk observed with silhouettes at age 8 and
at menarche were slightly more accentuated after additional
adjustment for adult BMI, adult regularity of menstrual cycles
and for interval between menarche and regular cycling, with RRs
equal to 0.73 (0.53–0.99) and 0.82 (0.66–1.02) for women who
chose a silhouette equal or greater than the fifth silhouette at age 8
and at menarche, respectively, as compared to women choosing
the first (data not shown). No significant linear relation was
found between silhouette at age 20–25 and breast cancer risk,
irrespective of menopausal status. However, we observed an
increased risk of premenopausal breast cancer among women who
chose the second silhouette at this age, with RRs of 1.35 (1.07–
1.70), as compared to those choosing the first silhouette (Table 2).
Later adjustments for adult BMI, adult regularity of menstrual
cycles and for interval between age at menarche and age at regular
cycling did not materially change the results.
Table 2 RRs of breast cancer by body silhouette at different ages. E3N study, 1990–2000




Silhouette at age 8
1 490 155593 1.00 (reference) 1.00 (reference) 1.00 (reference)
2 173 68759 0.85 (0.71–1.01) 0.84 (0.71–1.00) 0.88 (0.71–1.09)
3 124 44808 0.93 (0.76–1.13) 0.91 (0.75–1.11) 0.95 (0.74–1.21)
4 60 26709 0.75 (0.57–0.98) 0.73 (0.56–0.96) 0.69 (0.49–0.97)
X5 21 7813 0.84 (0.54–1.32) 0.84 (0.54–1.32) 0.82 (0.46–1.47)
P for trend* o0.01 o0.01 o0.05
Silhouette around menarche
1 171 60763 1.00 (reference) 1.00 (reference) 1.00 (reference)
2 315 99207 1.23 (1.03–1.47) 1.23 (1.03–1.47) 1.20 (0.97–1.50)
3 224 78310 1.11 (0.92–1.34) 1.13 (0.93–1.37) 1.03 (0.82–1.31)
4 134 52716 0.98 (0.79–1.21) 0.97 (0.77–1.20) 0.90 (0.68–1.19)
X5 40 17908 0.86 (0.61–1.21) 0.86 (0.61–1.21) 0.79 (0.51–1.22)
P for trend* o0.05 o0.05 o0.05
Silhouette at age 20–25
1 66 28313 1.00 (reference) 1.00 (reference) 1.00 (reference)
2 418 133410 1.33 (1.06–1.66) 1.35 (1.07–1.70) 1.26 (0.94–1.68)
3 293 111187 1.12 (0.89–1.41) 1.14 (0.90–1.45) 1.13 (0.84–1.52)
4 97 35457 1.14 (0.86–1.51) 1.13 (0.84–1.51) 1.11 (0.77–1.60)
X5 22 9314 0.99 (0.62–1.56) 1.01 (0.63–1.61) 0.97 (0.54–1.76)
P for trend* NS NS NS
Postmenopausal women
Silhouette at age 8
1 1 357 349402 1.00 (reference) 1.00 (reference) 1.00 (reference)
2 446 127097 0.94 (0.85–1.05) 0.95 (0.85–1.05) 0.97 (0.85–1.10)
3 299 82286 0.97 (0.86–1.10) 0.98 (0.86–1.11) 0.99 (0.85–1.15)
4 177 51588 0.92 (0.79–1.08) 0.93 (0.79–1.09) 0.87 (0.72–1.07)
X5 49 16973 0.77 (0.58–1.03) 0.76 (0.57–1.02) 0.69 (0.48–1.01)
P for trend* o0.05 o0.05 o0.01
Silhouette around menarche
1 598 148043 1.00 (reference) 1.00 (reference) 1.00 (reference)
2 811 206646 1.05 (0.96–1.16) 1.07 (0.97–1.18) 1.07 (0.95–1.21)
3 527 149494 0.95 (0.85–1.06) 0.96 (0.86–1.08) 0.99 (0.86–1.14)
4 316 98130 0.87 (0.77–1.00) 0.88 (0.77–1.01) 0.83 (0.70–0.98)
X5 120 35545 0.91 (0.75–1.11) 0.91 (0.75–1.10) 0.84 (0.66–1.08)
P for trend* o0.001 o0.001 o0.001
Silhouette at age 20–25
1 296 72926 1.00 (reference) 1.00 (reference) 1.00 (reference)
2 1 021 277394 0.95 (0.84–1.06) 0.95 (0.84–1.07) 0.97 (0.84–1.13)
3 778 221901 0.91 (0.80–1.02) 0.91 (0.80–1.04) 0.90 (0.75–1.03)
4 271 73285 0.95 (0.81–1.11) 0.97 (0.82–1.13) 0.97 (0.79–1.17)
X5 80 21625 0.95 (0.74–1.20) 0.94 (0.73–1.19) 0.93 (0.68–1.25)
P for trend* NS NS NS
RR¼relative risk; FFTP¼first full-term pregnancy; NS¼nonsignificant.
aAdjusted for menopause, age at menarche, age at FFTP, parity, marital status, number of years at school,
height, alcohol consumption, familial history of breast cancer in first-degree relatives, personal history of benign breast disease, oral contraceptive use and physical activity.
bAdditionally adjusted for BMI at baseline (1990), regularity of menstrual cycles when adult, interval between age at menarche and onset of regular cycling. *Performed on the
continuous variable ranked from 1 to 5+.
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yLogistic regression models (Table 3) to determine if menstrual-
related variables and BMI in adulthood were associated with
adiposity during childhood. Compared to women with a silhouette
of 4 or less at menarche, those with a silhouette greater than or
equal to 5 tended to be younger at menarche (Ptrendo0.0001, odds
ratio (OR)¼0.57 (0.52–0.62) for age at menarche X14 vs o12),
had a longer interval between menarche and regular cycling
(Ptrendo0.005, OR¼1.24 (1.15–1.34) for an interval 42 years vs
0), had more often irregular menstrual cycles in adult life
(OR¼1.16 (1.07–1.27)) and were more adipose at baseline
(Ptrendo0.0001, OR¼1.70 (1.46–1.97) for women in the fourth
vs women in the first quartile). Having a large silhouette at
adolescence was not related to age at regular cycling, except when
the latter occurred after age 15 (OR¼1.18 (1.10–1.28)). Similar
results were observed for silhouette at age 8.
Subgroup analyses (Table 4) indicated similar patterns of risks
with silhouette at age 8 irrespective of age at menarche, delay
between age at menarche, regular cycling, regularity of cycles in
adult life or BMI at inclusion. Similar conclusions were found for
adiposity at menarche. No test for heterogeneity between trends in
risk by subgroups reached significance.
DISCUSSION
Our results support the hypothesis of a protective effect of
adiposity at young ages on breast cancer risk, irrespective of
menopausal status, although the magnitude of the effect was not
strong and although the CIs around the RRs for obese girls often
included unity. Since adjustment for menstrual and anthropo-
metric characteristics in adulthood did not attenuate our
estimates, our results suggest that adiposity during adolescence
may have an independent protective effect against breast cancer.
No clear association was found between silhouette at age 20–25
and risk.
Few studies have focused on the relation between high weight
at (or around) menarche and risk (Le Marchand et al, 1988;
Franceschi et al, 1996; Hu et al, 1997; Magnusson et al, 1998;
Coates et al, 1999; Alghren et al, 2004; De Stavola et al, 2004;
Weiderpass et al, 2004). Most of these studies showed results quite
similar to ours, with a reduction especially of premenopausal
risk among women who had a high BMI during childhood (Le
Marchand et al, 1988; Coates et al, 1999; Weiderpass et al, 2004).
A case–control study nested within a historical cohort in Hawaii
(Le Marchand et al, 1988) showed a significant negative
association of premenopausal risk with high body mass at age
10–14. A lower risk was found for women who considered
themselves heavier than average at ages 12–13 and 15–16 (Coates
et al, 1999). The use of Sørensen’s body silhouettes for adiposity at
age 7, showed a significant and strong negative association of
increasing body silhouette at that age with postmenopausal breast
cancer risk, with a three-fold RR for those who had chosen the
leanest shape as their age 7 silhouettes, as compared to the largest
(Magnusson et al, 1998). Three prospective cohort studies have
found a significant decrease in risk with childhood adiposity:
a Scandinavian cohort study (Weiderpass et al, 2004) showed
a decreased risk of premenopausal breast cancer among women
who were the heaviest girls at age 7 (RR¼0.69 (0.51–0.93)), when
Table 3 Factors associated to a silhouette equal or greater than the 5th (logistic regression), at age 8 and around menarche. E3N study
Silhouette at age 8 Silhouette at menarche
Variables o5( n) X5( n) Adjusted OR
a o5( n) X5( n) Adjusted OR
a
Age at menarche (years)
o12 16752 692 1.00 (reference) 16339 1389 1.00 (reference)
[12–13[ 19928 574 0.76 (0.68–0.85) 19572 1331 0.85 (0.78–0.92)
[13–14[ 20129 439 0.60 (0.53–0.68) 19908 1013 0.67 (0.61–0.73)
X14 22774 453 0.56 (0.49–0.63) 22595 955 0.57 (0.52–0.62)
P for trend Po0.0001 Po0.0001
Age at regular cycles
b(years)
o12 30622 921 1.00 (reference) 30285 1900 1.00 (reference)
[12–13[ 6244 193 0.88 (0.74–1.02) 6132 405 0.88 (0.79–1.00)
[13–14[ 7794 212 0.92 (0.78–1.07) 7624 477 1.00 (0.90–1.11)
[14–15[ 14797 342 0.88 (0.78–1.01) 14604 771 0.97 (0.89–1.06)
X15 20115 490 1.04 (0.92–1.17) 19769 1135 1.18 (1.10–1.28)
P for trend Po0.01 Po0.01
Interval between age at menarche and age at regular cycles
b (years)
¼0 12930 311 1.00 (reference) 12787 630 1.00 (reference)
[0–1] 15945 430 0.99 (0.88–1.12) 15704 891 0.98 (0.90–1.06)
[1–2] 7942 189 0.88 (0.75–1.03) 7753 501 1.14 (1.03–1.26)
42 16237 478 1.14 (1.02–1.27) 15918 1073 1.24 (1.15–1.34)
P for trend Po0.01 Po0.01
Regularity of menstrual cycling when adult
b (years)
Yes 69430 1 836 1.00 (reference) 68389 4028 1.00 (reference)
No 10143 322 1.27 (1.12–1.44) 10025 660 1.16 (1.07–1.27)
BMI (kg/m
2) at baseline (1990)
o20.4 22050 279 1.00 (reference) 21672 657 1.00 (reference)
[20.4–22.0] 21631 448 1.43 (1.22–1.67) 21112 967 1.35 (1.21–1.50)
[22.0–24.0] 21703 609 1.72 (1.47–2.02) 20925 1387 1.78 (1.59–1.98)
X24.0 20699 801 1.73 (1.40–2.14) 19875 1625 1.70 (1.46–1.97)
P for trend Po0.0001 Po0.0001
OR¼odds ratio.
aOR (95% CI) adjusted for menopause, age at menarche, age at FFTP, parity, marital status, number of years at school, height, BMI, alcohol consumption, familial
history of breast cancer in first-degree relatives, personal history of benign breast disease, oral contraceptive use and physical activity.
bAge at menarche added as a confounder.
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yTable 4 RRs of breast cancer by body silhouette around menarche, according to menstrual characteristics and to BMI at inclusion E3N study, 1990–2000
Variables Cases (PY) Multivariate RRs
a Cases (PY) Multivariate RRs Cases (PY) Multivariate RRs Cases (PY) Multivariate RRs
Silhouette Around 8 years old Around menarche
Age at menarche o13 years Age at menarche X13 years Age at menarche o13 years Age at menarche X13 years
1 819 (209 031) 1.00 (reference) 1017 (292 984) 1.00 (reference) 309 (77 554) 1.00 (reference) 458 (130 126) 1.00 (reference)
2 305 (93 580) 0.88 (0.77–1.01) 311 (101 096) 0.95 (0.83–1.07) 526 (131 807) 1.11 (0.98–1.27) 589 (172 116) 1.10 (0.98–1.23)
3 217 (65 286) 0.91 (0.78–1.06) 204 (61 049) 1.01 (0.87–1.18) 370 (112 425) 0.95 (0.82–1.10) 380 (114 027) 1.05 (0.92–1.20)
4 135 (42 654) 0.86 (0.72–1.03) 102 (35 201) 0.88 (0.72–1.07) 261 (80 332) 0.93 (0.79–1.09) 188 (69 606) 0.85 (0.72–1.01)
X5 40 (14 245) 0.75 (0.54–1.03) 29 (10 353) 0.83 (0.57–1.21) 81 (30 363) 0.76 (0.60–0.96) 78 (22 646) 1.07 (0.84–1.36)
P for trend o0.01 ¼0.10 o0.001 o0.05
Interval p1 year Interval 41 year Interval p1 year Interval 41 year
1 695 (185 744) 1.00 (reference) 537 (152 369) 1.00 (reference) 304 (78 266) 1.00 (reference) 221 (61 042) 1.00 (reference)
2 232 (71 241) 0.93 (0.80–1.07) 187 (59 523) 0.91 (0.81–1.02) 424 (113 320) 1.05 (0.91–1.21) 323 (90 287) 1.14 (1.02–1.28)
3 159 (45 640) 0.98 (0.82–1.16) 127 (39 729) 0.96 (0.83–1.09) 266 (81 983) 0.92 (0.79–1.08) 238 (70 799) 1.05 (0.93–1.19)
4 86 (26 931) 0.90 (0.72–1.13) 65 (25 006) 0.86 (0.72–1.02) 154 (51 725) 0.84 (0.69–1.01) 132 (48 614) 0.94 (0.82–1.08)
X5 24 (8 526) 0.75 (0.49–1.14) 18 (7 724) 0.80 (0.60–1.08) 62 (17 374) 1.00 (0.76–1.31) 39 (18 127) 0.84 (0.67–1.04)
P for trend ¼0.07 o0.01 o0.05 o0.001
Irregular menstrual cycles in adulthood Regular menstrual cycles in adulthood Irregular menstrual cycles in adulthood Regular menstrual cycles in adulthood
1 231 (65 299) 1.00 (reference) 1616 (439 696) 1.00 (reference) 114 (28 680) 1.00 (reference) 655 (180 126) 1.00 (reference)
2 67 (23 659) 0.88 (0.67–1.16) 552 (172 197) 0.92 (0.83–1.01) 124 (38 165) 0.96 (0.75–1.23) 1002 (267 688) 1.13 (1.03–1.24)
3 55 (16 504) 1.05 (0.78–1.40) 368 (110 590) 0.95 (0.85–1.06) 92 (28 397) 0.96 (0.73–1.26) 659 (199 407) 1.01 (0.91–1.12)
4 35 (10 166) 1.06 (0.74–1.52) 202 (68 130) 0.84 (0.73–0.98) 54 (19 037) 0.86 (0.62–1.18) 396 (131 809) 0.91 (0.80–1.02)
X5 10 (3 717) 0.86 (0.46–1.63) 60 (21 070) 0.78 (0.60–1.01) 21 (7 532) 0.82 (0.52–1.31) 139 (45 922) 0.90 (0.75–1.08)






At baseline (1990) At baseline (1990) At baseline (1990) At baseline (1990)
1 1553 (430 261) 1.00 (reference) 270 (69 036) 1.00 (reference) 669 (184 973) 1.00 (reference) 88 (21 522) 1.00 (reference)
2 520 (162 534) 0.93 (0.85–1.03) 95 (31 477) 0.84 (0.67–1.06) 940 (256 953) 1.11 (1.01–1.22) 177 (45 836) 1.12 (0.89–1.42)
3 329 (99 590) 0.95 (0.84–1.07) 92 (26 338) 1.02 (0.81–1.29) 619 (181 855) 1.04 (0.93–1.15) 130 (43 351) 0.98 (0.72–1.19)
4 176 (59 526) 0.85 (0.72–0.99) 57 (17 913) 0.93 (0.70–1.23) 342 (119 426) 0.86 (0.76–0.98) 102 (29 974) 1.05 (0.80–1.37)
X5 52 (17 789) 0.81 (0.61–1.07) 18 (6 769) 0.77 (0.47–1.26) 118 (39 707) 0.88 (0.72–1.07) 40 (13 193) 0.94 (0.65–1.35)
P for trend o0.01 ¼0.20 o0.001 ¼0.22
RR¼relative risk; BMI¼body mass index; PY¼person-years.
adjusted for menopause, age at menarche, age at FFTP, parity, marital status, number of years at school, height, alcohol consumption, familial history of breast cancer in













































































































































ycompared to the thinnest; a high BMI at age 14 was associated with
a RR of 0.84 (0.75–0.94) in a Danish cohort (Alghren et al, 2004),
while another study found a reduced risk only with a high BMI
at ages 2–4 (De Stavola et al, 2004). Two others studies of
anthropometric data at age 12 had no significant results
(Franceschi et al, 1996; Hu et al, 1997). Some studies have
indicated that weight may be a risk modifier even earlier in life
(De Stavola et al, 2004). Unfortunately, birth weight and weight,
or adiposity, before age 8 were not available in our study. Overall
a decreased risk of premenopausal breast cancer has been found
with increasing adiposity around 20 years of age, while such
relation was less clear among postmenopausal women (IARC,
2002; Weiderpass et al, 2004). Overall our results were globally
nonsignificant whatever the menopausal status.
Excess adiposity can alter the production of hormones, notably
by increasing the frequency of anovulatory cycles (Stoll, 1997,
1998), which leads to a decrease in progesterone levels. In our data,
the percentage of women for whom menstrual cycles became
regular more than 1 year after menarche – which may indicate the
occurrence of anovulatory cycles – increased from 29 to 42% with
increasing body silhouette at menarche. Several studies associated
irregular menstrual cycles during life course to a lower risk of
breast cancer (Layde et al, 1989; Parazzini et al, 1993; Den
Tonkelaar and de Waard, 1996). Our observations and the fact that
the relationships observed were not modified by menstrual and
anthropometric characteristics in adulthood suggest that the
inverse relation of excess weight during childhood with risk later
in life, before or after menopause, may be explained by hormonal
mechanisms in the peripubertal period, when mammary tissue
develops.
As body silhouettes at age 8 and at menarche are highly
correlated, it is difficult to deduce if the protective effect in
our study is due to body fatness at age 8, to body fatness at
menarche or to both. To try to disentangle these two efforts, we
examined the associations between risk and overweight at age 8
among women with a silhouette lesser or equal to 3 at menarche,
and also overweight at menarche among those with a silhouette
lesser or equal to 3 at age 8. Both analyses showed similar
decreases in risk with increasing body silhouette, although the
decrease remained significant only with increasing silhouette at
menarche (P for trend o0.01), perhaps indicating that body
fatness at menarche is more relevant to the decreased risk
observed in this study.
As E3N participants have high levels of education and health
consciousness, our data can be considered reliable with very few
missing replies (around 5% for anthropometric variables). As a
prospective cohort, recall bias is prevented. The frequent updating
of our data (a questionnaire sent out every 2 years) allowed us to
determine accurately the menopausal status of the women and to
take account of this evolution in our analyses. Although we
included breast cancer cases that were not histologically con-
firmed, the great concordance between self-declaration of cancer
and pathology reports allowed us to strengthen the statistical
power of our study, and any misclassifications would only bias our
estimates towards unity.
However, the fact that the E3N cohort was not population based
may reduce the variability of many characteristics and conse-
quently bias our estimates towards unity. This study is based on
long-term memory of adiposity between childhood and young
adulthood, which may generate important error measurements
because many people cannot precisely evaluate their weight and
height in childhood, either because of difficulty of accurate recall
measurements or because they were not informed of their weight
when young. Nevertheless, several previous studies have shown a
reasonably high reliability of recalled body weight data, even after
long intervals (Stevens et al, 1990; Casey et al, 1991; De Fine
Olivarius and Andreasen, 1997). Moreover, the use of Sørensen’s
body silhouettes greatly facilitates the distant recall of body shape
and adiposity, during childhood. The use of silhouettes was
validated to estimate 33 years prior body shape on 448 women, and
showed that recalled silhouettes were overestimated by the
thinnest girls and underestimated by normal/heavier girls (Must
et al, 2002). However, such misclassifications would only bias our
estimates towards unity. Silhouettes may therefore offer an easier
and more accurate estimate of categories of past obesity.
In summary, our results support the hypothesis that obesity
during childhood or adolescence reduces breast cancer risk, and
that this reduction is not fully explained by menstrual character-
istics after menarche nor by adult BMI, but these results need
confirmation; further research is also required to analyse the
hormonal characteristics of overweight adolescents and to assess
whether hormonal modifications related to overweight at adoles-
cence persist in adult life.
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